BIO-TECHNE CORP (TECH)

US09073M1045 - Common Stock

71.92  +0.01 (+0.01%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
931M
26.03%
1.106B
18.75%
1.137B
2.81%
1.197B
5.30%
EBITDA
YoY % growth
332.6M
42.50%
399.3M
20.05%
400.8M
0.38%
401.33M
0.13%
N/A
EBIT
YoY % growth
244.9M
62.51%
298.2M
21.76%
293.6M
-1.54%
374.98M
27.72%
Operating Margin
26.31%26.97%25.83%31.33%
EPS
YoY % growth
1.68
48.12%
1.97
17.73%
2.00
1.01%
1.88
-5.57%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.46
-13.04%
Revenue
Q2Q % growth
298.69M
1.56%
EBITDA
Q2Q % growth
100.6M
EBIT
Q2Q % growth
96.325M
21.93%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
0.40
-14.89%
0.42-0.02-4.95%
Q1 2024
Q2Q % growth
0.41
-7.87%
0.44-0.03-7.65%
Q4 2023
Q2Q % growth
0.55
7.32%
0.56-0.01-1.39%
Q3 2023
Q2Q % growth
0.53
-0.93%
0.54-0.01-1.60%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
272.598M
0.37%
283.08M-10.482M-3.70%
Q1 2024
Q2Q % growth
276.9M
2.67%
293.16M-16.26M-5.55%
Q4 2023
Q2Q % growth
301.3M
4.55%
313.39M-12.09M-3.86%
Q3 2023
Q2Q % growth
294.1M
1.27%
302.59M-8.49M-2.81%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-7.79% -10% 0% -7.27%
Revenue-3.6% -5.12% 0% -4.85%